Home › Funds › Harpswell Capital Advisors, LLC › CLB
Harpswell Capital Advisors, LLC position in CLB
CORE LABORATORIES INC · Energy
Harpswell Capital Advisors, LLC reported holding 11,700 shares of CLB (CORE LABORATORIES INC) in its Q3 2026 13F filing — a position valued at US$113K, representing 0.07% of its reported portfolio and ranking #43 among its reported holdings. Harpswell Capital Advisors, LLC has disclosed CLB holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-10-09 · Source: SEC EDGAR Form 13F-HR
How Harpswell Capital Advisors, LLC's CLB position evolved
Harpswell Capital Advisors, LLC first disclosed a stake in CLB in Q2 2026 at 11,654 shares (US$136K). Across 2 filings, Harpswell Capital Advisors, LLC held the position steady without any share-count change. The most recent filing (Q3 2026) shows 11,700 shares valued at US$113K.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 11.65K | $135.77K | New |
| Q3 2026 | 11.70K | $113.49K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CLB and 13F data
CLB (CORE LABORATORIES INC) is a Energy company. 15 other funds we track also report a position in CLB — the largest reported positions include ARIEL INVESTMENTS, LLC (US$164.0M), DISCIPLINED GROWTH INVESTORS INC /MN (US$35.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CLB
- ARIEL INVESTMENTS, LLC 14.07M sh · $163.97M · Q2 2026
- DISCIPLINED GROWTH INVESTORS INC /MN 3.04M sh · $35.44M · Q2 2026
More on Harpswell Capital Advisors, LLC
FAQ
How long has Harpswell Capital Advisors, LLC held CLB?
Harpswell Capital Advisors, LLC has disclosed CLB holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is Harpswell Capital Advisors, LLC's current position in CLB?
As of Q3 2026, Harpswell Capital Advisors, LLC holds 11.70K shares of CLB (CORE LABORATORIES INC), valued at $113.49K, representing 0.07% of its reported portfolio and ranking #43.
Has Harpswell Capital Advisors, LLC been buying or selling CLB?
In the latest 13F filing (Q3 2026), Harpswell Capital Advisors, LLC held unchanged its position in CLB.
Which other funds hold CLB?
Other major institutional holders of CLB include ARIEL INVESTMENTS, LLC, DISCIPLINED GROWTH INVESTORS INC /MN, among 15 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.